Oxford Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Oxford Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,332	Closed	-$130K	–	2203
2019 Q3	$130K	Sell	8,332 -59	-0.7%	-$1.13K	﹤0.01%	1615
2019 Q2	$188K	Buy	8,391 +7,765	+1,240%	+$376K	﹤0.01%	1561
2019 Q1	$43K	Sell	626 -1,002	-62%	-$64.3K	﹤0.01%	1605
2018 Q4	$86K	Buy	1,628 +891	+121%	+$56.9K	﹤0.01%	1667
2018 Q3	$51K	Buy	+737	New	+$66.8K	﹤0.01%	1655

Other funds holding SRRA

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Oxford Asset Management's SRRA Position: Q4 2019 in Review

Oxford Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2019, closing a stake of 8,332 shares — an estimated $130K sold.

Oxford Asset Management first reported a position in SRRA in Q3 2018 and held it in 5 quarters. The position peaked at $188K in Q2 2019. 29 funds tracked by Wall St. Rank hold SRRA as of Q4 2019.

Oxford Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 8,332 Sierra Oncology, Inc. Common Stock shares in Q4 2019, an estimated $130K.
Oxford Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Oxford Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $188K in Q2 2019.
29 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.